Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• Asıl Yazarlar: Rory Barry (Yazar), Gregg Murray (Yazar), Sally McGrath (Yazar), Clive Kilgallen (Yazar), Karen Eustace (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Wiley, 2024-09-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...